Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch
23rd September 2019
Blogs
25th June 2019
Coventry, UK, 25th June 2019 / Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a u
Press Releases
14th June 2019
Medherant enjoyed a great evening at the Midlands BVCA Management Team Awards last night.
General News
21st May 2019
Coventry, UK, 21st May 2019 / Medherant Limited (“Medherant”), the clinical-stage developer of innovative transdermal delivery products for pain and CNS dise
Press Releases
13th February 2019
Pain affects everyone at some time in their life, be it chronic arthritis or a one-off injury.
Blogs
11th February 2019
Medherant has been included in the Silicone Republic Europe Start-up 100 for 2019 which looks at the companies to watch this year in e-commerce and fintech, deeptech, hardware and IoT, and medtech and life sciences.
General News
21st January 2019
Last year was another busy year for Medherant with a significant milestone reached when we received positive results from the first clinical trials with our TEPI Patch® technology.
Blogs